Inventor · disambiguated record
Gregor Zlokarnik
Also filed as: ZLOKARNIK GREGOR
26 granted patents·21 pending applications·1,289 citations·filing 1995–2018
98Inventor score
Top patents by PatentIndex Score
47 records- 0198US8796308B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Aug 5, 2014·73 cites·4 claims
- 0298US8765957B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 1, 2014·73 cites·3 claims
- 0397US9751839B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2016·Granted Sep 5, 2017·41 cites·3 claims
- 0497US9371287B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Granted Jun 21, 2016·55 cites·29 claims
- 0597US8835639B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Sep 16, 2014·72 cites·28 claims
- 0696US8614325B2Modulators of cystic fibrosis transmembrane conductance regulatorYANG XIAOQING·Filed 2011·Granted Dec 24, 2013·74 cites·12 claims
- 0796US8476442B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2010·Granted Jul 2, 2013·89 cites·13 claims
- 0895US6472205B1Cytosolic forms for β-lactamase and uses thereofUNIV CALIFORNIA·Filed 2000·Granted Oct 29, 2002·58 cites·35 claims
- 0995US5741657AFluorogenic substrates for β-lactamase and methods of useUNIV CALIFORNIA·Filed 1995·Granted Apr 21, 1998·169 cites·18 claims
- 1094US6291162B1Cytosolic forms of beta-lactamase and uses thereofUNIV CALIFORNIA·Filed 1996·Granted Sep 18, 2001·55 cites·24 claims
- 1192US6638713B2Optical molecular sensors for cytochrome P450 activityAURORA BIOSCIENCES CORP·Filed 2001·Granted Oct 28, 2003·23 cites·10 claims
- 1290US6221612B1Photon reducing agents for use in fluorescence assaysAURORA BIOSCIENCES CORP·Filed 1998·Granted Apr 24, 2001·76 cites·31 claims
- 1387US6143492AOptical molecular sensors for cytochrome P450 activityAURORA BIOSCIENCES CORP·Filed 1999·Granted Nov 7, 2000·41 cites·79 claims
- 1487US6031094ABeta-lactam substrates and uses thereofUNIV CALIFORNIA·Filed 1998·Granted Feb 29, 2000·39 cites·27 claims
- 1586US6514687B1Optical molecular sensors for cytochrome P450 activityVERTEX PHARMA SAN DIEGO LLC·Filed 1999·Granted Feb 4, 2003·34 cites·25 claims
- 1684US5955604ASubstrates for β-lactamase and uses thereofUNIV CALIFORNIA·Filed 1997·Granted Sep 21, 1999·83 cites·24 claims
- 1783US7067324B2Photon reducing agents for fluorescence assaysINVITROGEN CORP·Filed 2001·Granted Jun 27, 2006·15 cites·39 claims
- 1883US6214563B1Photon reducing agents for reducing undesired light emission in assaysAURORA BIOSCIENCES CORP·Filed 1998·Granted Apr 10, 2001·68 cites·89 claims
- 1982US6200762B1Photon reducing agents and compositions for fluorescence assaysAURORA BIOSCIENCES CORP·Filed 1998·Granted Mar 13, 2001·88 cites·48 claims
- 2081US8071761B2Substrates for beta-lactamase and uses thereofTSIEN ROGER Y·Filed 2006·Granted Dec 6, 2011·2 cites·12 claims
- 2175US6420130B1Optical molecular sensors for cytochrome P450 activityAURORA BIOSCIENCES CORP·Filed 1999·Granted Jul 16, 2002·37 cites·63 claims
- 2273US8247532B2Deuterated hepatitis C protease inhibitorsPERNI ROBERT B·Filed 2010·Granted Aug 21, 2012·1 cites·20 claims
- 2373US7157575B2Substrates for β-lactamase and uses thereofUNIV CALIFORNIA·Filed 2002·Granted Jan 2, 2007·2 cites·10 claims
- 2471US7132252B2Methods for detecting the interaction of compounds with cytochrome P450 using optical molecular sensorsINVITROGEN CORP·Filed 2002·Granted Nov 7, 2006·4 cites·15 claims
- 2565US2014350281A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2664US2017327456A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 2762US2005136469A1Photon reducing agents for fluorescence assaysINVITROGEN CORP A DELAWARE COR·Filed 2005·Application pending·0 cites
- 2862US2014303205A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2959US2012122921A1Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2011·Application pending·0 cites
- 3058US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3158US2019038615A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 3257US2014315948A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 3357US2013338188A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3457US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3556US2018153874A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 3654US2016221952A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3753US2007225297A1Deuterated hepatitis C protease inhibitorsPERNI ROBERT B·Filed 2007·Application pending·0 cites
- 3852US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3952US2012258983A1Pharmaceutical Composition and Administrations ThereofROWE WILLIAM·Filed 2012·Application pending·0 cites
- 4051US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4149US6284461B1Use of inhibitors in reporter assaysAURORA BIOSCIENCES CORP·Filed 1998·Granted Sep 4, 2001·15 cites·14 claims
- 4249US2007072256A1Optical molecular sensors for cytochrome p450 activityINVITROGEN CORP·Filed 2006·Application pending·0 cites
- 4349US2016067239A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4447US2010256184A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 4546US8153828B2Optical molecular sensors for cytochrome P450 activityMAKINGS LEWIS·Filed 2009·Granted Apr 10, 2012·2 cites·6 claims
- 4639US2011257223A1Modulators of Cystic Fibrosis Transmembrane Conductance RegulatorVERTEX PHARMA·Filed 2011·Application pending·0 cites
- 4739US2012220625A1Pharmaceutical composition and administrations thereofROWE WILLIAM·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregor Zlokarnik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →